AbsorbaSeal™ is a next-generation Vascular Closure Device (VCD) platform engineered to set a new standard in vascular access management. Featuring a streamlined, three-step deployment process, AbsorbaSeal™ is designed for intuitive use by clinicians, minimizing procedure time and enhancing workflow efficiency. Its fully bioabsorbable sealing mechanism promotes natural vessel healing without leaving permanent implants behind, while improving patient comfort.
In addition to its clinical advantages, AbsorbaSeal™ delivers significant economic value by potentially reducing complication-related costs and optimizing resource utilization for healthcare providers. By integrating innovation, safety, and efficiency, the AbsorbaSeal™ VCD platform represents a clinically and economically valuable solution for modern vascular closure needs.
Advancements in Medical Technologies
CyndRx has pioneered intellectual property, design, and commercialization for some of the industry’s most successful medical technologies.
Shaping the future in the medical field
CyndRx’s ongoing commitment ensures that we continue to provide innovative solutions that shape the future of healthcare and improve patient outcomes.
The platform’s unique scalability accommodates a wide range of access sizes from small to large bore (5F to 22F) making it versatile for diverse clinical applications, including complex interventional and surgical procedures.
